Free Trial

Talis Biomedical (TLIS) SEC Filings & 10K Form

Talis Biomedical logo
$1.72
0.00 (0.00%)
(As of 11/1/2024 ET)

Recent Talis Biomedical SEC Filings

DateFilerForm TypeView
10/10/2024
4:01 PM
BAKER BROS. ADVISORS LP (Filed by)
Talis Biomedical (Subject)
Form SC 13D/A
09/30/2024
5:05 AM
Talis Biomedical (Filer)
Form 15-12G
09/20/2024
7:57 AM
Nasdaq Stock Market LLC (Filed by)
Talis Biomedical (Subject)
Form 25-NSE
09/09/2024
3:32 PM
Talis Biomedical (Filer)
Form S-8 POS
09/09/2024
3:33 PM
Talis Biomedical (Filer)
Form S-8 POS
09/09/2024
3:37 PM
Talis Biomedical (Filer)
Form S-8 POS
09/09/2024
3:37 PM
Talis Biomedical (Filer)
Form S-8 POS
09/09/2024
3:24 PM
Leonard Braden Michael (Reporting)
Talis Biomedical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
4:11 PM
Talis Biomedical (Filer)
Form 8-K/A
09/05/2024
10:57 AM
Leonard Braden Michael (Reporting)
Talis Biomedical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:19 PM
Leonard Braden Michael (Reporting)
Talis Biomedical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
4:13 PM
Talis Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
3:23 PM
Talis Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
3:12 PM
Talis Biomedical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
8:23 PM
BML Investment Partners, L.P. (Filed by)
Talis Biomedical (Subject)
Form SC 13G/A
08/14/2024
8:13 PM
Leonard Braden Michael (Reporting)
Talis Biomedical (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
7:44 PM
BML Investment Partners, L.P. (Filed by)
Talis Biomedical (Subject)
Form SC 13G
08/14/2024
3:27 PM
Talis Biomedical (Filer)
Form NT 10-Q
08/07/2024
6:45 PM
Talis Biomedical (Issuer)
Young John T. Jr. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
6:48 PM
Ferrari Patricia (Reporting)
Talis Biomedical (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2024
3:25 PM
Talis Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:49 PM
Talis Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:04 AM
Talis Biomedical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/11/2024
3:53 PM
Talis Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2024
11:15 PM
Talis Biomedical (Filer)
Form EFFECT
03/28/2024
8:08 AM
Talis Biomedical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
3:39 PM
Talis Biomedical (Filer)
Form POS AM
02/14/2024
3:47 PM
GREENLIGHT CAPITAL INC (Filed by)
Talis Biomedical (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TLIS) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners